Olmesartan medoxomil, amlodipine and hydrochlorothiazide

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 31722-893
  • Package NDC 31722-893-30
  • Package NDC 31722-893-32
  • Package NDC 31722-893-90
  • Application number ANDA209242
  • SPL ID 47b1c419-e608-66b1-e063-6394a90ae253
  • SPL set ID 45e975ff-07b1-411a-96ee-a011d1619b1e
  • UNII 6M97XTV3HD
  • UNII 0J48LPH2TH
  • UNII 864V2Q084H
  • RxCUI 999967
  • RxCUI 999986
  • RxCUI 999991
  • RxCUI 999996
  • RxCUI 1000001

What the source publishes

Labeler
Camber Pharmaceuticals, Inc.
Active ingredients
Olmesartan medoxomil, amlodipine and hydrochlorothiazide
Form
TABLET, FILM COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:31722-893_47b1c419-e608-66b1-e063-6394a90ae253
{
  "name": "Olmesartan medoxomil, amlodipine and hydrochlorothiazide",
  "splId": "47b1c419-e608-66b1-e063-6394a90ae253",
  "labels": [
    {
      "setId": "45e975ff-07b1-411a-96ee-a011d1619b1e",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=45e975ff-07b1-411a-96ee-a011d1619b1e",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=45e975ff-07b1-411a-96ee-a011d1619b1e"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Camber Pharmaceuticals, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET, FILM COATED in 1 BOTTLE (31722-893-30)",
      "package_ndc": "31722-893-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20251006"
    },
    {
      "sample": false,
      "description": "10 BLISTER PACK in 1 CARTON (31722-893-32)  / 8 TABLET, FILM COATED in 1 BLISTER PACK (31722-893-31)",
      "package_ndc": "31722-893-32",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20251006"
    },
    {
      "sample": false,
      "description": "90 TABLET, FILM COATED in 1 BOTTLE (31722-893-90)",
      "package_ndc": "31722-893-90",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20251006"
    }
  ],
  "productId": "31722-893_47b1c419-e608-66b1-e063-6394a90ae253",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED",
  "productNdc": "31722-893",
  "deaSchedule": null,
  "genericName": "Olmesartan medoxomil, amlodipine and hydrochlorothiazide",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "OLMESARTAN MEDOXOMIL",
      "strength": "40 mg/1"
    },
    {
      "name": "AMLODIPINE BESYLATE",
      "strength": "5 mg/1"
    },
    {
      "name": "HYDROCHLOROTHIAZIDE",
      "strength": "12.5 mg/1"
    }
  ],
  "applicationNumber": "ANDA209242",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20251006",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175359",
      "N0000175419",
      "M0471776"
    ],
    "upc": [
      "0331722894906",
      "0331722896306",
      "0331722894302",
      "0331722895309",
      "0331722893305",
      "0331722892902",
      "0331722895903",
      "0331722896900",
      "0331722892308",
      "0331722893909"
    ],
    "unii": [
      "6M97XTV3HD",
      "0J48LPH2TH",
      "864V2Q084H"
    ],
    "rxcui": [
      "999967",
      "999986",
      "999991",
      "999996",
      "1000001"
    ],
    "spl_set_id": [
      "45e975ff-07b1-411a-96ee-a011d1619b1e"
    ],
    "pharm_class_cs": [
      "Thiazides [CS]"
    ],
    "pharm_class_pe": [
      "Increased Diuresis [PE]"
    ],
    "pharm_class_epc": [
      "Thiazide Diuretic [EPC]"
    ],
    "manufacturer_name": [
      "Camber Pharmaceuticals, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:31722-893_47b1c419-e608-66b1-e063-6394a90ae253"